Chicago Partners Investment Group LLC

Position in TSHA — Taysha Gene Therapies, Inc.

CIK 1563525 CHICAGO, IL

Position in TSHA

as of Jun 30, 2026 · filed Jul 30, 2026 Compact

Position Value

$1,514,183

+$750,927 QoQ

Shares Held

222,347

+30.2% QoQ

Ownership

0.068%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

#82

of 208 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Chicago Partners Investment Group LLC holds $16,750,273 across 43 Biotechnology names. TSHA ranks #1 (9.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TSHA	Taysha Gene Therapies, Inc. This page	222,347	$1,514,183
2	REGN	Regeneron Pharmaceuticals, Inc.	2,209	$1,377,399
3	JAZZ	Jazz Pharmaceuticals plc	5,326	$1,283,406
4	VRTX	Vertex Pharmaceuticals Inc / Ma	2,455	$1,219,472
5	CING	Cingulate Inc.	188,429	$1,030,706
6	EXEL	Exelixis, Inc.	18,752	$1,020,296
7	RPRX	Royalty Pharma plc	14,923	$836,732
8	BMRN	Biomarin Pharmaceutical Inc	12,109	$692,876

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,514,183	222,347	+30.2%	Shares	Sole	2026-07-30
2026-03-31	$763,256	170,751	+2.5%	Shares	Sole	2026-05-04
2025-12-31	$915,975	166,541	+1.5%	Shares	Sole	2026-01-28
2025-09-30	$536,400	164,037	+0.2%	Shares	Sole	2025-10-30
2025-06-30	$378,299	163,766	+40.5%	Shares	Sole	2025-07-29
2025-03-31	$162,025	116,565	+0.4%	Shares	Sole	2025-05-09
2024-12-31	$200,756	116,044	-1.8%	Shares	Sole	2025-01-24
2024-09-30	$237,531	118,175	+1.1%	Shares	Sole	2024-10-29
2024-06-30	$261,867	116,905	-6.7%	Shares	Sole	2024-07-31
2024-03-31	$359,565	125,284	-7.1%	Shares	Sole	2024-04-25
2023-12-31	$238,686	134,851	+21.4%	Shares	Sole	2024-02-23
2023-09-30	$351,110	111,111	—	Shares	Sole	2023-10-26
No filing history on record for this holder in this stock.